Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
24.40
+0.52 (2.18%)
Jun 29, 2026, 2:14 PM EDT - Market open
Sanara MedTech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 107.51 | 103.12 | 86.67 | 64.99 | 45.84 | 24.14 | |
Revenue Growth (YoY) | 17.41% | 18.97% | 33.36% | 41.77% | 89.87% | 54.90% |
Cost of Revenue | 7.61 | 7.52 | 8.14 | 7.85 | 6.36 | 2.31 |
Gross Profit | 99.9 | 95.6 | 78.53 | 57.14 | 39.48 | 21.83 |
Selling, General & Admin | 83.39 | 78.72 | 71.67 | 56.99 | 45.98 | 28.05 |
Depreciation & Amortization Expenses | 2.98 | 2.66 | 2.79 | 3.68 | 2.37 | 0.6 |
Research & Development | 3.05 | 5.07 | 2.83 | 4.13 | 3.37 | 0.56 |
Other Operating Expenses | - | 1.84 | -0.01 | -3.45 | 0.28 | - |
Total Operating Expenses | 89.42 | 88.29 | 77.27 | 61.35 | 52 | 29.21 |
Operating Income | 7.66 | 7.3 | 1.26 | -4.22 | -12.52 | -7.38 |
Interest Income | 0.01 | 0 | 0.02 | - | - | - |
Interest Expense | -7.24 | -6.76 | -3.13 | -0.48 | -0.38 | -0 |
Other Non-Operating Income (Expense) | -1.27 | -0.94 | -0.09 | 0.25 | -1.04 | -0.62 |
Total Non-Operating Income (Expense) | -8.5 | -7.7 | -3.2 | -0.22 | -1.42 | -0.62 |
Pretax Income | -0.84 | -0.39 | -1.94 | -4.44 | -13.94 | -7.99 |
Provision for Income Taxes | - | - | - | - | -5.84 | - |
Net Income | -0.84 | -0.39 | -1.94 | -4.44 | -8.09 | -7.99 |
Minority Interest in Earnings | -0 | -0.01 | -0.49 | -0.14 | -0.15 | -0.07 |
Earnings From Discontinued Operations | - | -37.17 | -7.97 | - | - | - |
Net Income to Common | -31.97 | -37.56 | -9.66 | -4.3 | -7.94 | -7.92 |
Shares Outstanding (Basic) | 9 | 9 | 8 | 8 | 8 | 7 |
Shares Outstanding (Diluted) | 9 | 9 | 8 | 8 | 8 | 7 |
Shares Change (YoY) | 2.01% | 1.64% | 2.48% | 4.71% | 7.70% | 28.02% |
EPS (Basic) | -0.27 | -4.36 | -1.14 | -0.52 | -1.00 | -1.08 |
EPS (Diluted) | -0.28 | -4.36 | -1.14 | -0.52 | -1.00 | -1.08 |
Free Cash Flow | 3.37 | 2.16 | -0.23 | -3.51 | -5.7 | -4.99 |
Free Cash Flow Growth | 56.10% | - | - | - | - | - |
Free Cash Flow Per Share | 0.39 | 0.25 | -0.03 | -0.42 | -0.72 | -0.68 |
Gross Margin | 92.92% | 92.71% | 90.61% | 87.92% | 86.12% | 90.43% |
Operating Margin | 7.12% | 7.08% | 1.45% | -6.49% | -27.30% | -30.55% |
Profit Margin | -0.78% | -0.38% | -2.24% | -6.83% | -17.65% | -33.11% |
FCF Margin | 3.14% | 2.10% | -0.26% | -5.40% | -12.44% | -20.65% |
EBITDA | 11.07 | 11.25 | 6.18 | -0.54 | -10.15 | -6.78 |
EBITDA Margin | 10.29% | 10.91% | 7.13% | -0.83% | -22.13% | -28.08% |
EBIT | 7.66 | 7.3 | 1.26 | -4.22 | -12.52 | -7.38 |
EBIT Margin | 7.12% | 7.08% | 1.45% | -6.49% | -27.30% | -30.55% |
Effective Tax Rate | - | 0.00% | 0.00% | 0.00% | 41.94% | 0.00% |